Neurological complications of coronary angiographic procedures

References

• National Center for Health Statistics. 1999 National Hospital Discharge Survey, Annual Summary with detailed diagnosis and procedure data. US Dept. of Health and Human Services, DC, USA 151 (2001).
   Google Scholar
• Lazar JM, Uretsky BF, DenysBG, Reddy PS, Counihan PJ, Ragosta M. Predisposing risk factors and natural history of acute neurological complication of left-sided cardiac catheterization. Am. J. Cardiol.75, 1056–1060 (1995).
   PubMed Web of Science ®Google Scholar
• Busing, KA, Schulte-Sasse C, Fluchter S et al. Cerebral infarction, Incindence and risk factors after diagnostic interventional cardiac catheterization – prospective evaluation at diffusion weighted MR imaging. Neuroradiology235, 177–183 (2005).
   Google Scholar
• Junck L, Marshall WH. Neurotoxicity of radiological contrast agents. Ann. Neurol.13, 469–484 (1983).
   PubMed Web of Science ®Google Scholar
• Liu XY, Wong V, Leung M. Neurological complications due to catheterization. Pediatr. Neurol.24, 270–275 (2001).
   PubMed Web of Science ®Google Scholar
• Weissman B, Aram DM, Levinsohn WM et al. Neurological sequelae of cardiac catheterization. Cathet. Cardiovasc. Diagn.11, 577–583 (1985).
   PubMedGoogle Scholar
• Gellen B, Remp T, Mayer T, Milz P, Franz WM. Cortical blindness: a rare but dramatic complication following coronary angiography. Cardiology99, 57–59 (2003).
   PubMed Web of Science ®Google Scholar
• Henzlova MJ, Coghlan HC, Dean LS, Taylor JL. Cortical blindness after left internal mammary artery to left anterior descending coronary artery graft angiography, Cathet. Cardiovasc. Diagn.15, 37–39 (1988).
   PubMedGoogle Scholar
• Sticherling C, Berkefeld J, Auch-Schwelk W, Lanfermann H. Transient bilateral cortical blindness after coronary angiography (letter). Lancet351, 570 (1998).
   PubMed Web of Science ®Google Scholar
• Antonellis J, Kostopoulos K, Rambaouni A et al. Cortical blindness following coronary arteriography: a rare but self-cured complication. Angiology47, 803–806 (1996).
   PubMedGoogle Scholar
• Kinn RM, Breisblatt WM. Cortical blindness after coronary angiography: a rare but reversible condition. Cathet. Cardiovasc. Diagn.22, 177–179 (1991).
   Google Scholar
• Parry R, Rees JR, Wilde P. Transient cortical blindness after coronary angiography. Br. Heart J.70, 563–564 (1993).
   PubMedGoogle Scholar
• Kwok BWK, Lim TT. Cortical blindness following coronary angiography. Singapore Med. J.41, 604–605 (2000).
   PubMedGoogle Scholar
• Zwicker JC, Sila CA. MRI findings in a case of transient cortical blindness after cardiac catheterization, Cathet. Cardiovasc. Diagn.57, 47–49 (2002).
   Google Scholar
• Rama BN, Pagano TV, DelCore M, Knobel KR, Lee J. Cortical blindness after cardiac catheterization: effect of rechallenge with dye. Cathet. Cardiovasc. Diagn.28, 149–151 (1993).
   PubMedGoogle Scholar
• Lantos G. Cortical blindness due to osmotic disruption of the blood-brain barrier by angiographic contrast material, CT and MRI studies. Neurology39, 567–571 (1989).
   PubMed Web of Science ®Google Scholar
• Kermode AG, Chakera T, Mastaglia FL. Low-osmolar and non-ionic x-ray contrast media and cortical blindness. Clin. Exp. Neurol.29, 272–276 (1992).
   PubMedGoogle Scholar
• Tamaki K, Sadoshima S, Heistad DD. Increased susceptibility to osmotic dirsruption of the blood–brain barrier in chronic hypertension. Hypertension6, 633–638 (1984).
   PubMedGoogle Scholar
• Gottesman RF, Sherman PM, Grega MA et al. Watershed stroke after cardiac surgery: diagnosis, etiology, and outcome. Stroke37, 2306–2311 (2006).
   PubMed Web of Science ®Google Scholar
• Khatri P, Kasner SE. Ischemic strokes after cardiac catheterization, opportune thrombolysis candidates. Arch. Neurol.63, 817–821 (2006).
   PubMedGoogle Scholar
• Dukkipati S, O’Neill WW, Harjai KJ et al. Characteristics of cerebrovascular accidents after percutaneous coronary interventions. J. Am. Coll. Cardiol.43, 1161–1167 (2004).
   PubMed Web of Science ®Google Scholar
• Fuchs S, Stabile E, Kinnaird TD et al. Stroke complicating percutaneous coronary interventions, incidence, predictors, and prognostic implications. Circulation106, 86–91 (2002).
   PubMed Web of Science ®Google Scholar
• Segal AZ, Abernethy WB, Palacios IF, BeLue R, Rodford G. Stroke as a complication of cardiac catheterization: risk factors and clinical features. Neurology56, 975–977 (2001).
   PubMed Web of Science ®Google Scholar
• Omran H, Schmid H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterization of the aortic valve in valvular stenosis, a prospective, randomised study. Lancet361, 1241–1246 (2003).
   PubMed Web of Science ®Google Scholar
• Lund C, Nes RB, Ugelstad TP et al. Cerebral emboli during left heart catherization may cause acute brain injury. Eur. Heart J.26, 1269–1275 (2005).
   PubMed Web of Science ®Google Scholar
• Kosmorsky G, Hanson S, Tomsak R. Neuro-ophthalmologic complications of cardiac catheterization. Neurology38, 483–485 (1988).
   PubMedGoogle Scholar
• Hamon M, Gomes S, Oppenheim C et al. Cerebral microembolism during cardiac catheterization and risk of acute brain injury. Stroke37, 2035–2038 (2006).
   PubMed Web of Science ®Google Scholar
• Fisher A, Ozbek C, Bay W, Hamann GF. Cerebral microemboli during left heart catheterization, Am. Heart J.137, 162–168 (1999).
   PubMedGoogle Scholar
• Stygall J, Kong R, Walker JM et al. Cerebral microembolism detected by Transcranial Doppler during cardiac procedures. Stroke31, 2508–2510 (2000).
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Luft AR, Sharma M et al. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures, part I, pathophysiological and pharmacological features. Neurosurgery46, 1344–1359 (2000).
   PubMed Web of Science ®Google Scholar
• Bladin CF, Bingham L, Grigg L et al. Transcranial Doppler detection of microemboli during percutaneous transluminal coronary angioplasty. Stroke29, 2367–2370 (1998).
   PubMed Web of Science ®Google Scholar
• Piessens JH, Stammen F, Vrolix MC et al. Effects of an ionic versus an nonionic low osmolar contrast agent on the thrombotic complications of coronary angioplasty. Cath. Cardiovasc. Diagn.28, 99–105 (1993).
   PubMedGoogle Scholar
• Keeley EC, Grines CL. Scraping of aortic debris by coronary guiding catheters. J. Am. Coll. Cardiol.23, 1862–1865 (1998).
   Google Scholar
• Akkerhuis KM, Deckers JW, Lincoff AM et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervenion. JAMA286, 78–82 (2001).
   PubMedGoogle Scholar
• Mahaffey KW, Granger CB, Sloan MA et al. Risk factors for in-hospital non-hemorrhagic stroke in patients with acue myocardial infarction treated with thrombolysis, resultsfor GUSTO-I. Circulation97, 757–764. (1998).
   PubMed Web of Science ®Google Scholar
• Collins R, MacMahon S, Flather M et al. Clinical effects of anticoagulation therapy in suspected acute myocardial infarction, systematic overview of randomized trials. BMJ313, 652–659 (1996).
   PubMed Web of Science ®Google Scholar
• Brenner SJ, Moliterno DJ, Lincoff AM et al. Relationship between activated clotting time and ischemic or hemorrhagic complications analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation110, 994–998 (2004).
   PubMedGoogle Scholar
• Keilson GR, Schwartz WJ, Recht LD. The preponderance of posterior circulatory events is independent of the route of cardiac catheterization. Stroke23, 1358–1359 (1992).
   PubMedGoogle Scholar
• Dawson DM, Fischer EG. Neurological complications of cardiac catheterization. Neurology27, 496–497 (1977).
   PubMedGoogle Scholar
• Leclercq F, Kassnasrallah S, Cesari JB et al. Transcranial Doppler detection of cerebral microemboli during left heart catheterization. Cerebrovasc. Dis.12, 59–65 (2001).
   PubMedGoogle Scholar
• Brown DL, Topol J. Stroke complicating percutaneous coronary revascularization. Am. J. Cardiol.72, 1207–1209 (1993).
   PubMed Web of Science ®Google Scholar
• NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med.333, 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g), results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators. Stroke31, 811–816 (2000).
   PubMed Web of Science ®Google Scholar
• Del Zoppo GJ, Higashida R, Furlan A et al. PROACT, a Phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery occlusion. Stroke35, 705–709 (2004).
   PubMedGoogle Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute arterial ischemic stroke, The PROACT-II Study: a randomized control trial, Prolyse in acute cerebral thromboembolism. JAMA282, 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Zaidat OO, Slivka AP, Mohammad Y et al. Intra-arterial thrombolytic therapy in peri-coronary angiography ischemic stroke. Stroke36, 1089–1090 (2005).
   PubMedGoogle Scholar
• Al-Mubarak N, Vitek JJ, Mousa I et al. Immediate catheter based neurovascular rescue for acute stroke complicating coronary procedures. Am. J. Cardiol.90, 173–176 (2002).
   PubMed Web of Science ®Google Scholar
• Sandoval AE, Laufer N. Thromboembolic stroke complicating coronary intervention, acute evaluation and management in the cardiac catheterization laboratory. Cathet. Cardiovasc. Diagn.44, 412–414 (1998).
   PubMedGoogle Scholar
• Chan AW, Henderson MA. Immediate catheter-directed reperfusion for acute stroke occurring during diagnostic cardiac catheterization. Catheter. Cardiovasc. Interv.67, 314–318 (2006).
   PubMedGoogle Scholar